Breast Cancer Pharmacology (medical)

Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies

Aya Imai, Ryo Tsunashima, Yu Hidaka, Sae Kitano, Chikage Kato, Akira Watanabe, Midori Morita, Koichi Sakaguchi, Yoshiaki Sota, Masahiko Suzuki, Takayuki Kinoshita, Seiichi Imanishi, Masahiro Oikawa, Yoshihiko Kamada, Ken-ichi Ito, Takaaki Oba, Shin Takayama, Fumine Tsukamoto, Mina Takahashi, Yutaka Hatanaka, Naoto T. Ueno, Kenzo Shimazu, Satoshi Morita, Yasuto Naoi
Springer Nature · 2025-06-25 · DOI 10.1007/s12282-025-01734-2

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →